Dr Agarwal’s IPO closes today: Key details

Andrew Dubbs
2 Min Read
Dr Agarwal's IPO closes today: Key details

The subscription window for the initial public offering (IPO) of Dr Agarwal’s Health Care Ltd closes today. The Rs 3,027.26-crore public issue has been subscribed 96%. The category for Qualified Institutional Buyers (QIBs) received 1.96 times subscription.

The IPO has a price band of Rs 382 to Rs 402 per share with a face value of Re 1. The lot size for this IPO is 35 equity shares, with investments being made in multiples of 35 equity shares thereafter.

Dr Agarwal’s IPO details

The allotment of shares is expected to be finalized on February 3, 2025. Dr Agarwal’s Health Care shares are anticipated to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on February 5, 2025. The IPO comprises a fresh issue of up to Rs 300 crore and an offer for sale (OFS) of up to 6.78 crore equity shares worth Rs 2,727.26 crore by promoters and other selling shareholders at the upper end of the price band.

Ahead of the IPO, Dr Agarwal’s Health Care raised over Rs 875.5 crore from anchor investors, including Temasek Holdings and TPG. The book-running lead managers for the issue are Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India, and Motilal Oswal Investment Advisors. Dr Agarwal’s Health Care provides a wide array of services, including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.

Share This Article
Andrew covers investing for considerable.com. He writes on the latest news in the stock market and the economy.